The REMDACTA trial: do interleukin receptor antagonists provide additional benefit in COVID-19?

OA Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494625/

Author(s)

Tatham, Kate C

Shankar-Hari, Manu

Arabi, Yaseen M

Type

Journal Article

Date Issued

2021-10-07

Date Acceptance

2021-09-17

Citation

Intensive Care Medicine, 2021, 47, pp.1315-1318

URI

http://hdl.handle.net/10044/1/92307

DOI

https://www.dx.doi.org/10.1007/s00134-021-06540-w

ISSN

0342-4642

Publisher

Springer

Start Page

1315

End Page

1318

Journal / Book Title

Intensive Care Medicine

Volume

47

Copyright Statement

© 2021, Springer-Verlag GmbH Germany, part of Springer Nature.

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000705792900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Critical Care Medicine

General & Internal Medicine

Publication Status

Published